BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 36010271)

  • 1. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
    Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
    Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
    Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.
    Soliman A; De Sanctis V; Yassin M; Abdelrahman MO
    Indian J Endocrinol Metab; 2014 Jan; 18(1):32-8. PubMed ID: 24701427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and Endocrine Function in Tunisian Thalassemia Major Patients.
    Dhouib NG; Ben Khaled M; Ouederni M; Besbes H; Kouki R; Mellouli F; Bejaoui M
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018031. PubMed ID: 29755708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thalassemia.
    Galanello R; Origa R
    Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.
    Yang WP; Chang HH; Li HY; Lai YC; Huang TY; Tsai KS; Lin KH; Lin DT; Jou ST; Lu MY; Yang YL; Chou SW; Shih SR
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31907538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH).
    De Sanctis V; Daar S; Soliman A; Tzoulis P; Di Maio S; Kattamis C
    Acta Biomed; 2023 Aug; 94(4):e2023195. PubMed ID: 37539597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients.
    De Sanctis V; Skordis N; Galati MC; Raiola G; Giovannini M; Candini G; Kaffe K; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():290-4. PubMed ID: 21705980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
    De Sanctis V; Elsedfy H; Soliman AT; Elhakim IZ; Pepe A; Kattamis C; Soliman NA; Elalaily R; El Kholy M; Yassin M
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016001. PubMed ID: 26740862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.
    Metwalley KA; El-Saied AR
    Indian J Endocrinol Metab; 2014 May; 18(3):333-9. PubMed ID: 24944927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.